The Analysis of Heart Rate Variability With 24hrs Holter ECG and Serum Cardiac Fibrosis Markers in Critical Illness Patients Who Are With Cardiogenic Shock, With ECMO or IABP Support, or With APACH II Score >25)

NCT01993745 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 106

Last updated 2013-11-25

No results posted yet for this study

Summary

The study is to show the prognostic factor of HRV parameter and cardiac fibrosis markers in critical illness patients

Conditions

  • Cardiogenic Shock,
  • With ECMO or IABP Support,
  • With APACH II Score >25)

Sponsors & Collaborators

  • National Taiwan University Hospital

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2008-05-31
Primary Completion
2009-05-31
Completion
2009-12-31

Countries

  • Taiwan

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01993745 on ClinicalTrials.gov